BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12023872)

  • 1. Receptors for insulin and insulin-like growth factor-1 and insulin receptor substrate-1 mediate pathways that regulate islet function.
    Kulkarni RN
    Biochem Soc Trans; 2002 Apr; 30(2):317-22. PubMed ID: 12023872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
    Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.
    Cantley J; Choudhury AI; Asare-Anane H; Selman C; Lingard S; Heffron H; Herrera P; Persaud SJ; Withers DJ
    Diabetologia; 2007 Jun; 50(6):1248-56. PubMed ID: 17393136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines.
    Kulkarni RN; Winnay JN; Daniels M; BrĂ¼ning JC; Flier SN; Hanahan D; Kahn CR
    J Clin Invest; 1999 Dec; 104(12):R69-75. PubMed ID: 10606633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.
    Withers DJ; Burks DJ; Towery HH; Altamuro SL; Flint CL; White MF
    Nat Genet; 1999 Sep; 23(1):32-40. PubMed ID: 10471495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor substrate proteins and neuroendocrine function.
    Withers DJ
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):525-9. PubMed ID: 11498021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development.
    Accili D; Nakae J; Kim JJ; Park BC; Rother KI
    J Pediatr Endocrinol Metab; 1999; 12(4):475-85. PubMed ID: 10417963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3.
    Kulkarni RN; Roper MG; Dahlgren G; Shih DQ; Kauri LM; Peters JL; Stoffel M; Kennedy RT
    Diabetes; 2004 Jun; 53(6):1517-25. PubMed ID: 15161756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into insulin action and secretion.
    Rhodes CJ; White MF
    Eur J Clin Invest; 2002 Jun; 32 Suppl 3():3-13. PubMed ID: 12028370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice.
    Otani K; Kulkarni RN; Baldwin AC; Krutzfeldt J; Ueki K; Stoffel M; Kahn CR; Polonsky KS
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E41-9. PubMed ID: 14519599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes.
    Ueki K; Okada T; Hu J; Liew CW; Assmann A; Dahlgren GM; Peters JL; Shackman JG; Zhang M; Artner I; Satin LS; Stein R; Holzenberger M; Kennedy RT; Kahn CR; Kulkarni RN
    Nat Genet; 2006 May; 38(5):583-8. PubMed ID: 16642022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
    Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
    Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes outfoxed by GLP-1?
    Holz GG; Chepurny OG
    Sci STKE; 2005 Jan; 2005(268):pe2. PubMed ID: 15671479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does IGF-I stimulate pancreatic islet cell growth?
    Liu JL
    Cell Biochem Biophys; 2007; 48(2-3):115-25. PubMed ID: 17709881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.
    Kubota N; Tobe K; Terauchi Y; Eto K; Yamauchi T; Suzuki R; Tsubamoto Y; Komeda K; Nakano R; Miki H; Satoh S; Sekihara H; Sciacchitano S; Lesniak M; Aizawa S; Nagai R; Kimura S; Akanuma Y; Taylor SI; Kadowaki T
    Diabetes; 2000 Nov; 49(11):1880-9. PubMed ID: 11078455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor.
    Kitamura T; Kido Y; Nef S; Merenmies J; Parada LF; Accili D
    Mol Cell Biol; 2001 Aug; 21(16):5624-30. PubMed ID: 11463843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes?
    Sesti G
    Ann Med; 2002; 34(6):444-50. PubMed ID: 12523500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRS proteins and beta-cell function.
    Burks DJ; White MF
    Diabetes; 2001 Feb; 50 Suppl 1():S140-5. PubMed ID: 11272176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass.
    Kulkarni RN; Holzenberger M; Shih DQ; Ozcan U; Stoffel M; Magnuson MA; Kahn CR
    Nat Genet; 2002 May; 31(1):111-5. PubMed ID: 11923875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.